PEPG
PepGen Inc.
Key Financials
Net Income
$-89655000
↑ 0.4%
EPS (Diluted)
$-2.12
↑ 25.6%
Shareholders' Equity
$147.4M
↑ 24.3%
Total Assets
$173.9M
↑ 15.3%
Total Liabilities
$26.5M
↓ 18.0%
Cash & Equivalents
$60.5M
↑ 22.4%
Operating Income
$-93612000
↑ 4.2%
Operating Cash Flow
$-81635000.00
↑ 0.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 3/30/2026 | View on SEC |
| SCHEDULE 13G | 3/11/2026 | View on SEC |
| 4 | 3/6/2026 | View on SEC |
| 4 | 3/6/2026 | View on SEC |
| 4 | 3/6/2026 | View on SEC |
| 8-K | 3/4/2026 | View on SEC |
| S-8 | 3/4/2026 | View on SEC |
| 10-K | 3/4/2026 | View on SEC |
| 8-K | 3/4/2026 | View on SEC |
| 4 | 3/2/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PEPG |
| Company Name | PepGen Inc. |
| CIK | 1835597 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 703-456-8000 |